ClinicalTrials.gg
RecruitingNCT05723081OK-SNAPIIIUpdated Apr 2, 2025

Oklahoma Study of Native American Pain Risk III: Stress and Resilience

An observational study in Discrimination, Racial, Stress Physiology and Pain, sponsored by University of Oklahoma. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-02.

Sponsored by University of Oklahoma · Observational

How we know

From the registry’s dates

  • Started Feb 2023; still recruiting 3 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
220
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 37 studies in Racism with a site in United States — 4 open to participants now, 9 under way, 1 of them phase 3. Racism · United States.

Started
2023
with 11 others
Observational
7 of 37
1 open now
Registered
31st of 37
by date

Among the 37 studies in Racism with a site in United States, this one is one of 12 that started in 2023, is one of 7 observational ones, and was the 31st registered.

Racism

48 studies on the registry are indexed under Racism; 9 are open to participants now.

Browse Racism studies →

Open to participants now

4 of the 37 studies in Racism with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 5 Racism studies recruiting now, 2 set no upper age limit and 2 stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Racism with a site in United States, or all of them as a file.
02

Study summary

The goal of this observational study is to learn about the relationship between environmental structural racism and discrimination and chronic pain risk in Native American adults. The main questions it aims to answer are:

  1. How does environmental structural racism and discrimination affect chronic pain-promoting mechanisms in Native Americans?
  2. What psychosocial factors buffer the negative effects of environmental structural racism and discrimination on chronic pain-promoting mechanisms?
Read the detailed description

Native Americans experience higher rates of chronic pain than the general U.S. population, and previous research has shown that pain-free Native Americans transition to chronic pain at almost three times the rate of non-Hispanic Whites. Yet, little is known about the mechanisms that contribute to this pain disparity.

This study aims to better understand the role of environmental and society-wide stressors, like structural racism and discrimination, in contributing to this pain disparity. It is believed that these environmental and social stressors may contribute to chronic pain risk by increasing an individual's mental and physical stress levels. In turn, increased stress may alter how an individual responds to pain, both physically and emotionally, which may place them at greater risk for developing chronic pain in the future.

03

Conditions studied

  • Discrimination, Racial
  • Stress Physiology
  • Pain

Browse trials for

Keywords

  • Structural racism and discrimination
  • Stress reactivity
  • Quantitative sensory testing
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants will be adults who self-identify as Native American/American Indian.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Self-identify as Native American/American Indian

Exclusion criteria

Exclusion Criteria:

  • \<18 years of age
  • Self-reported history of cardiovascular, neuroendocrine, musculoskeletal, or neurological disorders
  • Surrent chronic pain, defined as persistent, bothersome pain on more days than not for at least 3 months)
  • Self-reported current substance dependence
  • Sse of medication that could interfere with testing (e.g., recent use of analgesics, antidepressants, or anti-anxiety medications)
  • Inability to speak English
  • Current psychosis (assessed by Psychosis Screening Questionnaire)
  • Serious cognitive impairment (assessed by \<20 score on the [MoCA])
  • Possible peripheral neuropathy (assessed by nerve conduction study)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
220 participants (estimated)
Patient registry
No
Biospecimen retention
None retained

Groups and cohorts

  • Native Americans

    Native Americans / American Indians

06

What researchers measure

Primary outcomes

  1. Pain inhibition

    Pain inhibition will be assessed using a conditioned pain modulation task with cold water as the conditioning stimulus and electric stimulations as the test stimulus.

    Time frame: baseline

  2. Inhibition of pain-related spinal reflex

    Pain-related spinal reflex inhibition assessed from electromyogram will be assessed using a conditioned pain modulation task with cold water as the conditioning stimulus and electric stimulations as the test stimulus.

    Time frame: baseline

  3. Inhibition of pain-evoked cortical potentials

    Inhibition of pain-evoked cortical potentials from electroencephalography will be assessed using a conditioned pain modulation task with cold water as the conditioning stimulus and electric stimulations as the test stimulus.

    Time frame: baseline

  4. Psychological stress

    A single latent variable measuring psychological stress will be created using principal components analysis to combine scores from three self-report questionnaires: the Perceived Stress Scale (PSS), the Global Distress Index of the Symptom Checklist-90-Revised (SCL-90-R), and the PTSD Checklist-Civilian (PCL-C).

    Time frame: baseline

  5. Somatic threat sensitivity

    A single latent variable measuring somatic threat sensitivity will be created using principal components analysis to combine scores from the Pain Catastrophizing Scale and a pain-related anxiety visual analog scale.

    Time frame: baseline

  6. Allostatic load

    A single latent variable for allostatic load will be created using principal components analysis to combine cardiovascular (i.e., resting blood pressure and heart rate, stress-evoked blood pressure and heart rate, and a fasting lipids profile \[HDL, LDL total cholesterol, and triglycerides\]), metabolic (i.e., BMI, waist-to-hip ratio, HbA1c), neuroendocrine (i.e., diurnal salivary cortisol, stress-evoked salivary cortisol), immune (i.e., hs-CRP), and parasympathetic (i.e., resting heart rate variability) variables.

    Time frame: baseline

  7. Environmental structural racism and discrimination

    An index comprised of 11 environmental justice variables from the Environmental Protection Agency's publicly available Environmental Screening and Mapping Tool (EJSCREEN) will be created for each participant at the 2010 Census Block Group level. The 11 variables will be combined into a single index using principal components analysis.

    Time frame: baseline

  8. Cultural connectedness

    A single latent variable of cultural connectedness will be created using principal components analysis to combine scores from five self-report scales: the Cultural Connectedness Scale, the Community Mastery Scale, the Vancouver Index of Acculturation, the American Indian Enculturation Scale, and the Native American Spirituality Scale

    Time frame: baseline

Secondary outcomes

  1. Temporal summation of pain

    Temporal summation of pain will be measured by assessing the change in a participant's pain ratings in response identical noxious stimuli delivered in rapid succession.

    Time frame: baseline

  2. Temporal summation of spinal nociception

    Temporal summation of spinal nociception will be measured by assessing the change in a participant's pain-related reflex magnitude (assessed from electromyography) in response identical noxious stimuli delivered in rapid succession.

    Time frame: baseline

  3. Pain tolerance

    Pain tolerance will be measured with ischemic and cold pain tasks. Participants will continuously rate their pain in response to painful tonic stimuli, and pain tolerance will be quantified as the time (in seconds) that it takes for participants to report that they can no longer tolerate the pain.

    Time frame: basline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Immediately following publication of all findings, the data will be freely available to any researcher who requests a copy. All data files will be de-identified so there is no possibility of connecting the information with the original participants. The electronic data will be stored as de-identified SPSS data files or Excel data files. The raw (i.e., unprocessed) physiology data (e.g., EMG, EKG, EEG) will also be made available to interested researchers. These raw data files will be stored as de-identified files. To obtain access to the data, interested parties can contact the PI (jamie-rhudy@utulsa.edu).

Time frame: De-identified data will become available following publication of all findings (around 6/1/2030).

Access criteria: To obtain access to the data, interested parties can contact the PI (jamie-rhudy@utulsa.edu).

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2023 (actual). Primary completion is estimated for Mar 2027, 49 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2023
First posted
Feb 10, 2023
StartActual
Feb 3, 2023
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Apr 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05723081
Collaborators
Oklahoma State University, University of Tulsa
Responsible party
Sponsor
First posted
Feb 10, 2023
Start date
Feb 3, 2023
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Apr 2, 2025

Study contacts

PLAN Lab
Contact
tulsa.plan@gmail.com
918-660-3048
Jamie L Rhudy, PhD
Contact
jamie-rhudy@ouhsc.edu
918-660-3050
Jamie L Rhudy, PhD
principal investigator · University of Oklahoma

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion